Expression of CD133 has also been reported to be high in metastatic melanoma compared to primary melanoma, and CD133+ melanoma cells have higher clonogenic and tumorigenic abilities compared to CD133− cells [118, 119]. This evidence concerns the gene PROM1 and melanoma.